Small-cap inventory Archean Chemical Industries declined almost 4 per cent in intraday commerce on the BSE on Thursday, Might 8, wanting set to increase losses to the third consecutive session. Archean Chemical Industries share value opened at ₹603.25 in opposition to its earlier shut of ₹605.40 and declined 3.6 per cent to an intraday low of ₹583.45. Round 12:45 PM, the small-cap inventory traded 2.71 per cent decrease at ₹589. Fairness benchmark Sensex was nearly flat at 80,789 at the moment.
Archean Chemical Industries This fall outcomes 2025
The speciality chemical compounds firm introduced its Q4FY25 outcomes after market hours on Might 2. The corporate reported a 2.2 per cent year-on-year (YoY) decline in its revenue after tax (PAT) for the quarter to ₹58.31 crore from ₹59.64 crore in the identical quarter final 12 months.
Complete earnings, nonetheless, elevated 12 per cent to ₹333.33 crore from ₹297.22 crore in Q4FY24.
EBITDA in Q4FY25 noticed a gentle dip, coming at ₹101.12 crore from ₹101.94 crore in Q4FY24.
Axis Securities downgrades the inventory
Brokerage agency Axis Securities downgraded the inventory to a “maintain” from a “purchase”, pegging the goal value of ₹560.
Axis identified that the corporate’s Q4FY25 consolidated income beat its estimate by
17 per cent. Nonetheless, EBITDA fell wanting its estimates by 4 per cent, whereas the PAT additionally missed its estimate by 4 per cent.
Based on Axis Securities, Archean Chemical Industries stays assured in its bromine derivatives undertaking and the strategic acquisition of Oren, which is predicted to make a significant contribution to the highest line within the coming quarters.
Furthermore, Axis highlighted that the corporate anticipates sustained robust demand within the industrial salt phase and a restoration within the SOP phase starting in FY26.
Strategic investments have additionally been made in two UK- and US-based firms, that are anticipated to unlock new progress alternatives in semiconductors and vitality storage, Axis Securities stated.
Goldman Sachs, DIIs maintain stakes in Archean Chemical Industries
Based on the March quarter (Q3FY25) shareholding sample information, international portfolio buyers (FPIs) elevated their stake to 1,35,00,426 shares, aggregating to 10.94 per cent stake, within the firm from 1,31,38,918 shares, or 10.65 per cent stake by the tip of Q3FY25.
Goldman Sachs Funds by Goldman Sachs India Fairness Portfolio maintained its holding of 30,38,345 shares or a 2.46 per cent stake within the firm in Q4FY25.
Home Institutional Buyers (DIIs), which comprise mutual funds, insurance coverage firms, banks and NBFCs, pension and provident funds, alternate funding funds (AIFs) and improvement monetary establishments, additionally elevated their stake to 2,86,09,468 shares, or 23.18 per cent stake, from 2,82,08,506, or 22.85 per cent stake QoQ.
It seems Nippon Life India Trustee, HDFC Mutual Fund, and DSP Small Cap Fund trimmed their stakes within the firm in the course of the March quarter, as their names don’t seem within the shareholding sample information for the quarter.
In Q3FY25, Nippon Life India Trustee Ltd (Nippon India Small Cap Fund) held 1.17 per cent, HDFC Mutual Fund (HDFC Multi Cap Fund) held 1.53 per cent, DSP Small Cap Fund held 3.44 per cent, and SBI Small Cap Fund held 6.92 per cent stakes within the firm.
Alternatively, in Q4FY25, solely the SBI Small Cap Fund’s identify seems below the mutual funds class within the shareholding sample information obtainable with the BSE, which lowered its stake to 84,94,476 shares, or 6.88 per cent.
Learn all market-related information right here
Disclaimer: This story is for academic functions solely. The views and proposals above are these of particular person analysts or broking firms, not Mint. We advise buyers to examine with licensed consultants earlier than making any funding selections, as market circumstances can change quickly, and circumstances might fluctuate.
